- Education, Training & Outreach
- Patients & Caregivers
- For Investigators
- Dementia in the News
- Media Room
National Institute on Aging (October 1, 2012): Risk Gene for Alzheimer's Disease Associated with Lower Brain Amyloid
Researchers investigating a known gene risk factor for Alzheimer's dsiease discovered it is associated with lower levels of beta amyloid - a brain protein involved in Alzheimer's - in cognitively healthy older people. The findings suggest that a mechanism other than one related to beta amyloid accumulation may influence disease risk associated with the gene. The study, by researchers at the National Institute on Aging (NIA) at the National Institutes of Health, was published online September 27, 2012 in the journal Biological Psychiatry.
The scientists studied a variation in the complement receptor-1 (CR1) gene, a newly identified gene associated with risk for late-onset Alzheimer's disease, in cognitively normal older volunteers. Participants with this gene variant were found to have less brain amyloid than those without the risk variant. In addition, the CR1 gene variant was found to interact with APOE, the most robust genetic risk factor for Alzheimer's disease, to influence the amount of brain amyloid.
"The prevailing hypothesis has implicated factors increasing beta amyloid in the brain as an integral element of Alzheimer's disease pathology," said NIA Director Richard J. Hodes, M.D. "This study indicates the importance of exploring and understanding other distinct mechanisms that may be at work in this disease."
Using a brain scan called Pittsburgh Compound B positron emission tomography (PiB PET), the researchers measured brain amyloid in 57 cognitively normal older poeple with an average age of 78.5 in the Baltimore Longtidinal Study of Aging (BLSA).